コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 receptor (A2AR) has long been implicated in cardiovascular disorders.
2 target for the treatment of hypertension and cardiovascular disorders.
3 esistance and other features of T2DM such as cardiovascular disorders.
4 findings could have implications in various cardiovascular disorders.
5 ting effects in some autoimmune diseases and cardiovascular disorders.
6 increased morbidity and mortality in various cardiovascular disorders.
7 tabolic, oncological, neurodegenerative, and cardiovascular disorders.
8 in the treatment of hypertension and related cardiovascular disorders.
9 ective PDE5A inhibition for the treatment of cardiovascular disorders.
10 lasma protein that has beneficial actions on cardiovascular disorders.
11 nd inflammation may improve the treatment of cardiovascular disorders.
12 get for therapeutic intervention in ischemic cardiovascular disorders.
13 conditions have increased susceptibility to cardiovascular disorders.
14 present a novel mechanism in LVH and related cardiovascular disorders.
15 to influence the occurrence of a variety of cardiovascular disorders.
16 coarctation or recoarctation and concomitant cardiovascular disorders.
17 tion are early events in angiotensin-induced cardiovascular disorders.
18 sing therapeutic and biomarker candidate for cardiovascular disorders.
19 ing mechanisms leading to the onset of acute cardiovascular disorders.
20 identify the genetic abnormalities in other cardiovascular disorders.
21 nd is strongly associated with metabolic and cardiovascular disorders.
22 tagonist drugs are widely used in therapy of cardiovascular disorders.
23 ng diseases, such as cancer angiogenesis and cardiovascular disorders.
24 is closely related to various metabolic and cardiovascular disorders.
25 al window for intervention to prevent future cardiovascular disorders.
26 es, such as cancers, osteoporosis, lung, and cardiovascular disorders.
27 inhibitor is commonly used in patients with cardiovascular disorders.
28 lled trials of treatment duration in various cardiovascular disorders.
29 diseases, diabetes, infectious diseases, and cardiovascular disorders.
30 yopathy, one of the most prevalent heritable cardiovascular disorders.
31 s HIV and Hantavirus infection, diabetes and cardiovascular disorders.
32 the contributions of the expressed genome to cardiovascular disorders.
33 of age-related diseases, including multiple cardiovascular disorders.
34 ed with endothelial dysfunction in different cardiovascular disorders.
35 enes associated with psychiatric, immune and cardiovascular disorders.
36 ave a higher risk of other diseases, such as cardiovascular disorders.
37 occurrence of various pathologies including cardiovascular disorders.
38 c targets to treat dyslipidemias and related cardiovascular disorders.
39 s a disease-modifying therapeutic target for cardiovascular disorders.
40 w that LNK is associated with autoimmune and cardiovascular disorders.
41 eatly influences the pathogenesis of various cardiovascular disorders.
42 cation channel associated with a variety of cardiovascular disorders.
43 othyroidism as an epigenetic risk factor for cardiovascular disorders.
44 abetes mellitus is the major risk factor for cardiovascular disorders.
45 se potentially lethal, yet highly treatable, cardiovascular disorders.
46 otease of post-translational SUMOylation, in cardiovascular disorders.
47 been observed in sporadic neurocognitive and cardiovascular disorders.
48 maceuticals for the treatment of cancers and cardiovascular disorders.
49 rious pathological states such as cancer and cardiovascular disorders.
50 s to the pathogenesis of certain cancers and cardiovascular disorders.
51 connection between autophagy, mitophagy, and cardiovascular disorders.
52 ts, as well as diagnostics, for a variety of cardiovascular disorders.
53 invaluable resource for the study of certain cardiovascular disorders.
54 ecting the impact of chronic inflammation in cardiovascular disorders.
55 tates, such as pulmonary, hematological, and cardiovascular disorders.
57 e in obesity, which worsens the incidence of cardiovascular disorders and cancer, the 2 leading cause
59 opmental abnormalities and diseases, such as cardiovascular disorders and cancer; however, the stimul
63 erstanding of pathogenesis of several common cardiovascular disorders and may lead to the development
64 overlapping associations with autoimmune and cardiovascular disorders and other circulating biomarker
65 nflammation is associated with metabolic and cardiovascular disorders and PVN AT1a deletion reduced i
66 al anomalies and respiratory, endocrine, and cardiovascular disorders and was not associated with mor
67 d the pathophysiology of several inheritable cardiovascular disorders and will ultimately change the
68 icoagulant therapies, prevent and treat many cardiovascular disorders and, as such, are some of the m
69 tative solid tumor, and thrombosis, a common cardiovascular disorder, and demonstrate urinary detecti
70 d are the targets of drugs designed to treat cardiovascular disorders, and ACE inhibitors are commonl
72 G) is associated with systemic metabolic and cardiovascular disorders, and both share common risk fac
75 th disease symptoms such as peptic ulcers or cardiovascular disorders, and epidemiological studies st
76 ase, psychiatric disorders, renal disorders, cardiovascular disorders, and liver disease in Europe; h
77 bolic diseases such as obesity and diabetes, cardiovascular disorders, and neurological and cognitive
78 s in each of the subcategories of congenital cardiovascular disorders, and will provide the reader wi
80 such as nonalcoholic fatty liver disease and cardiovascular disorders are known to have a major infla
82 -3 fatty acids may be effective in epilepsy, cardiovascular disorders, arthritis, and as mood stabili
83 and treatment of subclinical or progressive cardiovascular disorders, as in acute coronary syndrome,
85 Pulmonary arterial hypertension (PAH) is a cardiovascular disorder associated with enhanced prolife
86 alue in human psychiatric, reproductive, and cardiovascular disorders associated with CRH system hype
88 be a promising strategy to lower the risk of cardiovascular disorders associated with obesity and typ
89 re targets to develop clinical therapies for cardiovascular disorders associated with oxidative stres
90 te to the known beneficial effects of BH4 in cardiovascular disorders associated with oxidative stres
91 as been implicated in asthma, autoimmune and cardiovascular disorders, but its role in other respirat
93 I) is a well-established participant in many cardiovascular disorders, but the mechanisms involved ar
94 lmarks of endothelial dysfunction leading to cardiovascular disorders, but the underlying molecular m
95 em (RAS) plays pathogenic roles in renal and cardiovascular disorders, but whether it is involved in
96 se and 1749 control participants free of any cardiovascular disorders by use of a validated ex-vivo r
97 of diabetic complications, and perhaps other cardiovascular disorders, by attenuating oxidative/nitra
100 Portal vein thrombosis (PVT) and different cardiovascular disorders (CVDs) were the indication for
101 been hypothesized to play a role in various cardiovascular disorders for over two decades, our resul
102 the interest in ACE as a candidate gene for cardiovascular disorders, has led to extensive investiga
104 duals without evident heart failure or other cardiovascular disorders, higher CRP was associated with
105 oding LNK are associated with autoimmune and cardiovascular disorders; however, it is not known how L
106 vasodilators are used to treat a variety of cardiovascular disorders; however, the signal transducti
107 placebo group and a pre-existing unspecified cardiovascular disorder in the abobotulinumtoxinA 500 U
109 ed with obesity, the metabolic syndrome, and cardiovascular disorders in observational and short-term
110 ecular basis for the observed higher risk of cardiovascular disorders in PTSD patients, which raises
111 ng ion channels or ion channel modulators in cardiovascular disorders including cardiac arrhythmia su
112 least studied complications of NF1 involves cardiovascular disorders, including arterial occlusions
113 apeutic targets for the treatment of several cardiovascular disorders, including cardiac arrhythmia a
114 ol consumption has long been associated with cardiovascular disorders, including cardiomyopathy, hype
115 e (cGMP) signaling has been observed in many cardiovascular disorders, including heart failure and pu
116 the treatment of epilepsy, chronic pain, and cardiovascular disorders, including hypertension, angina
118 reported to be at increased risk for various cardiovascular disorders, including left ventricular hyp
121 for cholesterol control among patients with cardiovascular disorders (increasing from 14 percent to
122 on that occurs in diverse conditions such as cardiovascular disorders, inflammatory diseases, and neo
123 nditions, correct differentiation from other cardiovascular disorders is important, because therapy o
125 tabolic syndrome, a cluster of metabolic and cardiovascular disorders, is systemic insulin resistance
126 reparticipation examination is to detect the cardiovascular disorders known to cause sudden cardiac a
128 of sex steroid hormones on the incidence of cardiovascular disorders, little is known about the neur
129 hanges in prescribing oral beta-blockers for cardiovascular disorders may affect the number of those
130 therapeutic targets for pathologies such as cardiovascular disorders, neurodegenerative diseases, an
131 gastrointestinal disorders (14 admissions), cardiovascular disorders (nine), sepsis syndrome (six),
133 ous types of imaging of the diseases such as cardiovascular disorders, obesity, and cancer where macr
134 nt to human health, including cancer, aging, cardiovascular disorders, obesity, infectious disease su
135 heral arterial disease (PAD) is an important cardiovascular disorder of the peripheral arteries.
137 from the realization that several hereditary cardiovascular disorders originate from gene mutations t
138 ill potentially enhance our understanding of cardiovascular disorders, particularly in patients whose
139 cytes generated from patients with inherited cardiovascular disorders recapitulate key phenotypic fea
140 used as a Chinese medicine for patients with cardiovascular disorders, selectively abrogated endotoxi
142 ty and mortality advantage for patients with cardiovascular disorders, similar benefits might also ac
144 r proportion of patients with NAFLD die from cardiovascular disorders than patients with ALD, whereas
145 pidemiological studies to a wide spectrum of cardiovascular disorders that are characterized by a dys
148 a critical pathway and therapeutic target in cardiovascular disorders, the involvement of this ectonu
149 The incidence and mortality of the major cardiovascular disorders vary sharply by occupation, but
151 regnancy-associated death (n = 50; 20%), and cardiovascular disorders were the second-leading cause (
152 cholesterol carries a risk for metabolic and cardiovascular disorders, whereas high-density lipoprote
153 iPSC-derived cardiomyocytes to study genetic cardiovascular disorders will enable a deeper and more a
154 Periodontal disease has been associated with cardiovascular disorders with an atherosclerotic backgro
155 Orthostatic hypotension (OH) is a common cardiovascular disorder, with or without signs of underl
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。